AAAAAA

   
Results: 1-8 |
Results: 8
INTERLEUKIN-2 GENE-MODIFIED ALLOGENEIC-TUMOR CELLS FOR TREATMENT OF RELAPSED NEUROBLASTOMA
Authors: BOWMAN LC GROSSMANN M RILL D BROWN M ZHONG WY ALEXANDER B LEIMIG T COUSTANSMITH E CAMPANA D JENKINS J WOODS D BRENNER M
Citation: Lc. Bowman et al., INTERLEUKIN-2 GENE-MODIFIED ALLOGENEIC-TUMOR CELLS FOR TREATMENT OF RELAPSED NEUROBLASTOMA, Human gene therapy, 9(9), 1998, pp. 1303-1311
IL-2 ADENOVECTOR-TRANSDUCED AUTOLOGOUS TUMOR-CELLS REDUCE ANTITUMOR IMMUNE-RESPONSES IN PATIENTS WITH NEUROBLASTOMA
Authors: BOWMAN L GROSSMANN M RILL D BROWN M ZHONG WY ALEXANDER B LEIMIG T COUSTANSMITH E CAMPANA D JENKINS J WOODS D KITCHINGMAN G VANIN E BRENNER M
Citation: L. Bowman et al., IL-2 ADENOVECTOR-TRANSDUCED AUTOLOGOUS TUMOR-CELLS REDUCE ANTITUMOR IMMUNE-RESPONSES IN PATIENTS WITH NEUROBLASTOMA, Blood, 92(6), 1998, pp. 1941-1949
PREDOMINANCE AND CHARACTERISTICS OF BURKITT-LYMPHOMA AMONG CHILDREN WITH NON-HODGKIN-LYMPHOMA IN NORTHEASTERN BRAZIL
Authors: SANDLUND JT FONSECA T LEIMIG T VERISSIMO L RIBEIRO R LIRA V BERARD CW SIXBEY J CRIST WM MAO L CHEN G PUI CH HEIM M PEDROSA F
Citation: Jt. Sandlund et al., PREDOMINANCE AND CHARACTERISTICS OF BURKITT-LYMPHOMA AMONG CHILDREN WITH NON-HODGKIN-LYMPHOMA IN NORTHEASTERN BRAZIL, Leukemia, 11(5), 1997, pp. 743-746
ANTITUMOR IMMUNE-RESPONSES INDUCED BY IL2 GENE MODIFIED TUMOR-CELLS IN CHILDREN WITH ADVANCED NEUROBLASTOMA
Authors: BOWMAN LC GROSSMAN M RILL DR BROWN MP ZHONG W ALEXANDER B LEIMIG T COUSTANSMITH E CAMPANA D JENKINS J WOODS D KITCHINGMAN G VANIN E BRENNER MK
Citation: Lc. Bowman et al., ANTITUMOR IMMUNE-RESPONSES INDUCED BY IL2 GENE MODIFIED TUMOR-CELLS IN CHILDREN WITH ADVANCED NEUROBLASTOMA, Blood, 90(10), 1997, pp. 1800-1800
HIGH-EFFICIENCY TRANSDUCTION OF FRESHLY ISOLATED HUMAN TUMOR-CELLS USING ADENOVIRAL INTERLEUKIN-2 VECTORS
Authors: LEIMIG T BRENNER M RAMSEY J VANIN E BLAESE M DILLOO D
Citation: T. Leimig et al., HIGH-EFFICIENCY TRANSDUCTION OF FRESHLY ISOLATED HUMAN TUMOR-CELLS USING ADENOVIRAL INTERLEUKIN-2 VECTORS, Human gene therapy, 7(10), 1996, pp. 1233-1239
GENETIC-MODIFICATION OF FIBROBLASTS TO GENERATE LEUKEMIA VACCINES
Authors: DILLOO D LEIMIG T MEI ZY BRENNER M
Citation: D. Dilloo et al., GENETIC-MODIFICATION OF FIBROBLASTS TO GENERATE LEUKEMIA VACCINES, Experimental hematology, 23(8), 1995, pp. 746-746
COSTIMULATORY SIGNALS CAN BE EFFECTIVELY DELIVERED BY GENE MODIFIED ACCESSORY CELLS IN A LEUKEMIA VACCINE
Authors: DILLOO D LEIMIG T ZHONG W MEI Z BRENNER M
Citation: D. Dilloo et al., COSTIMULATORY SIGNALS CAN BE EFFECTIVELY DELIVERED BY GENE MODIFIED ACCESSORY CELLS IN A LEUKEMIA VACCINE, Blood, 86(10), 1995, pp. 1852-1852
IMMUNOMODULATORY EFFECTS OF HUMAN NEUROBLASTOMA-CELLS TRANSDUCED WITHA RETROVIRAL VECTOR ENCODING INTERLEUKIN-2
Authors: LEIMIG T FOREMAN N RILL D COZE C HOLLADAY M BRENNER M
Citation: T. Leimig et al., IMMUNOMODULATORY EFFECTS OF HUMAN NEUROBLASTOMA-CELLS TRANSDUCED WITHA RETROVIRAL VECTOR ENCODING INTERLEUKIN-2, Cancer gene therapy, 1(4), 1994, pp. 253-258
Risultati: 1-8 |